Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human ...

An announcement from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On June 2, 2025, Telomir Pharmaceuticals announced its ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...

Hillstar Bio, a leading biotechnology company focused on developing immunology therapies for autoimmune diseases, appointed ...

On May 22, 2025, the FDA approved Bio-Thera Solutions and Hikma Pharmaceuticals’ ustekinumab biosimilar, STARJEMZA® (ustekinumab-hmny) ...

The need for drying technologies to stabilize drug products containing biologics Drug products containing active biological ...